Skip to main content

FDA Still Says Women Should Take Yaz

By June 22, 2011July 10th, 2019Uncategorized

The FDA issued a news release on May 31 that stated it is in the process of looking over two studies that show that Yaz and Yasmin makes women 2-3 times more likely to suffer from blood clots than women who took another form of birth control.

Both of the studies were published by the British Medical Journal (BMJ) on April 21 of this year. The studies don’t just say that Yaz and Yasmin cause blood clots, they also claim all other birth control pills that contain the synthetic progestin drosperinone cause increased risks of blood clots. Some of the other pills included in these study results are Beyaz, Safyral, Ocella and Zarah. Thousands of lawsuits have been filed against the makers of Yaz by women who have developed blood clots. Some women even died because of the adverse effects of the pills.

The FDA has finally taken a public stance on the pills, and they are standing by them… to a point. In fact, the FDA maintains that women should not stop taking the pills; however, they are urging them to contact their doctors immediately if they begin to experience any of the symptoms that could spell big trouble for their health. Some of the symptoms they are urging women to watch out for include “persistent leg pain, severe chest pain or sudden shortness of breath.”

The European equivalent of the FDA, the European Medicines Agency (EMA), announced that it is going to update the information and warning labels on Yaz, Yasmin and other birth control pills which contain drosperinone a few days before the FDA released that it was looking into the pills. The FDA standing behind women taking these pills may finally put to rest any questions that people have about a recall being issued.